Results 141 to 150 of about 60,681 (284)

Antiretroviral drug switches to zidovudine‐based regimens and loss to follow‐up during the first COVID‐19 lockdown in Bali, Indonesia [PDF]

, 2022
Keerti Gedela, Ngurah Rajus, Hendry Luis, Wayan Dede Fridayantara, Irwanto Irwanto, Evi Sukmaningrum, F. Stephen Wignall   +6 more
openalex   +1 more source

Differential Extracellular and Intracellular Concentrations of Zidovudine and Lamivudine in Semen and Plasma of HIV-1-Infected Men

, 2008
Julie B. Dumond, Y. Sunila Reddy, Luigi Troiani, José F. Rodrígúez, Arlene S. Bridges, Susan A. Fiscus, Geoffrey J. Yuen, Myron S. Cohen, Angela D. M. Kashuba   +8 more
openalex   +2 more sources

Immunovirological treatment out- comes after 2 years of antiretroviral therapy in children living with the human immune deficiency virus in Lagos Nigeria

Nigerian Journal of Paediatrics
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O, Akindele AJ, Akanmu AS, Adeyemi OO   +3 more
doaj  

Zidovudine to prevent mother-to-infant HIV transmission in developing countries: a view from Thailand. [PDF]

, 1999
Cawthorne, P, Kasi-Sedapan, S, Kumphitak, A, Lakhonphol, S, Sanaeha, S, Unchit, N, Wilson, D   +6 more
core   +1 more source

Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication [PDF]

, 1996
Angela M. Caliendo, Anu V. Savara, Daegi An, Kimberly M. Devore, Joan C. Kaplan, Richard T. D’Aquila   +5 more
openalex   +1 more source

Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria. [PDF]

BMC Infect Dis
Etuk VP, Adeoye IA, Salawu MM, Fawole OI.   +3 more
europepmc   +1 more source

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

Journal of the American Medical Association (JAMA), 1998
J. Montaner, P. Reiss, D. Cooper, S. Vella, M. Harris, B. Conway, M. Wainberg, Richard Smith, P. Robinson, D. Hall, M. Myers, J. Lange   +11 more
semanticscholar   +1 more source

Real-world effectiveness of antiretroviral backbone regimens on viral suppression in pediatric and adolescent HIV care: a six-year cohort study from Uganda. [PDF]

EClinicalMedicine
Ankunda C, Kyomuhangi B, Emunyu J, Namasambi S, Sserunjogi C, Nakawesi J.   +5 more
europepmc   +1 more source

Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection

, 1990
P. Volberding, S. Lagakos, M. Koch, C. Pettinelli, M. Myers, D. Booth, H. Balfour, R. Reichman, J. Bartlett, M. Hirsch, R. Murphy, W. Hardy, R. Soeiro, M. Fischl, J. Bartlett, T. Merigan, N. Hyslop, D. Richman, F. Valentine, L. Corey   +19 more
semanticscholar   +1 more source

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

New England Journal of Medicine, 1996
A. Collier, R. Coombs, D. Schoenfeld, Roland L. Bassett, Joseph G Timpone, A. Baruch, Michelle Jones, K. Facey, C. Whitacre, V. Mcauliffe, H. Friedman, T. Merigan, R. Reichman, C. Hooper, Lawrence Corey   +14 more
semanticscholar   +1 more source